Rett Syndrome: Why It Predominantly Affects Girls (X-Linked Genetics)

Rett syndrome is an X-linked dominant neurodevelopmental disorder caused by MECP2 mutations. It overwhelmingly affects females.

Genetic Basis

  • Gene: MECP2 (Xq28) — encodes methyl-CpG-binding protein 2, regulates gene expression.
  • Inheritance: >99% de novo mutations; rarely inherited from germline mosaic parent.
  • Male lethality: Males (46,XY) lack a second X → no functional MECP2 → severe neonatal encephalopathy, death <2 years (rare survivors: Klinefelter 47,XXY or somatic mosaicism).
  • Female survival: Random X-inactivation → mosaic expression → variable severity.

Incidence

  • Females: ~1 in 10,000–15,000 live births.
  • Males: ~1 in 500,000 (only with 47,XXY or mosaicism).

Clinical Features (Females)

  • Normal development 6–18 mo → regression (loss of speech, hand use, gait).
  • Stereotypic hand movements (wringing, washing).
  • Seizures, breathing abnormalities, scoliosis, growth failure.

Variable Expressivity

X-inactivation skewing, mutation type (missense vs. truncating), and modifiers cause wide severity range. Some females mildly affected.

Management

  • Multidisciplinary: neurology, orthopedics, GI, pulmonology, PT/OT/ST.
  • Trofinetide (FDA-approved 2023) modestly improves symptoms.
  • Gene therapy trials underway.

Genetic Disorders - Related Articles

Health Sciences © https://www.222health.com